Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Minoxidil is less effective on eyebrows and eyelashes than scalp hair because these areas have lower enzyme activity needed to activate the drug.

Using hair gel is an effective and patient-friendly way to keep hair out of the way during ear surgery.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

TA-Ado effectively promotes hair growth and reduces hair loss.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Higher IL-21 levels may help predict alopecia areata activity.

Low vitamin D can worsen pediatric alopecia areata.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Adenosine led to higher patient satisfaction than minoxidil for hair loss treatment.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Carcinosin, a homeopathic remedy, helped a young girl with alopecia areata regrow hair and reduce psychological symptoms.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

PRP is an effective and safe treatment for hair loss in women.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Androgenetic alopecia negatively impacts quality of life, especially for women, due to social reactions.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

C-scores can help predict gain-of-function and loss-of-function mutations.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

Some JAK inhibitors are effective for significant hair regrowth in alopecia areata.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.